ATHE Financials
Alterity Therapeutics Ltd - Financial statements & key metrics
Stock Price
$3.30
Market Cap
$62.53M
EPS
$-0.61
Income Statement Highlights
Most Recent Quarter: 2025-06-30
Revenue
$5.44M
Gross Profit
$5.31M
Operating Income
$-14.57M
Net Income
$-12.15M
EPS (Diluted)
$-
Balance Sheet Highlights
Total Assets
$46.03M
Total Liabilities
$3.62M
Shareholders Equity
$42.40M
Cash & Equivalents
$33.16M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-11.45M
CapEx
$0
Free Cash Flow
$-11.45M
Profitability Metrics
Gross Margin
97.7%
Operating Margin
-1.9%
Net Margin
-2.2%
ROE
-0.4%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is ATHE revenue?
ATHE's most recent quarterly revenue was $5.44M. Annual revenue can be calculated by summing the four most recent quarters.
Is ATHE profitable?
ATHE reported a loss of $12.15M in the most recent quarter. The net profit margin is -2.2%.
What is ATHE market cap?
ATHE has a market capitalization of $62.53M, making it a small-cap stock.
Does ATHE have debt?
View ATHE's balance sheet for debt information.
What is ATHE cash flow?
ATHE's most recent quarterly free cash flow was $-11.45M.